Berlin - Delayed Quote EUR

Protalix BioTherapeutics Inc (PBDA.BE)

Compare
2.1600
+0.0030
+(0.14%)
At close: January 10 at 8:08:24 AM GMT+1
Loading Chart for PBDA.BE
DELL
  • Previous Close 2.1570
  • Open 2.1600
  • Bid 2.1420 x --
  • Ask 2.2710 x --
  • Day's Range 2.1600 - 2.1600
  • 52 Week Range 0.7938 - 2.1600
  • Volume 0
  • Avg. Volume 3
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Mar 12, 2025 - Mar 17, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: PBDA.BE

View More

Performance Overview: PBDA.BE

Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

PBDA.BE
25.98%
S&P 500
1.35%

1-Year Return

PBDA.BE
35.00%
S&P 500
22.51%

3-Year Return

PBDA.BE
184.21%
S&P 500
24.59%

5-Year Return

PBDA.BE
40.64%
S&P 500
77.94%

Compare To: PBDA.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PBDA.BE

View More

Valuation Measures

As of 1/10/2025
  • Market Cap

    162.33M

  • Enterprise Value

    141.23M

  • Trailing P/E

    13.99

  • Forward P/E

    3.53

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.73

  • Price/Book (mrq)

    5.05

  • Enterprise Value/Revenue

    3.18

  • Enterprise Value/EBITDA

    5.63

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: PBDA.BE

View More